Literature DB >> 23909474

Critical need for appropriate mucosal sample collection to determine relational animal pharmacokinetic-pharmacodynamic models in HIV prevention.

Leslie Marshall1, James Cummins, Hans Spiegel, James Turpin, Fulvia Veronese, Angela Kashuba.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23909474      PMCID： PMC3809943          DOI： 10.1089/AID.2013.0142

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN： 0889-2229            Impact factor:   2.205


× No keyword cloud information.
  12 in total

Review 1.  Mucosal HIV-1 transmission and prevention strategies in BLT humanized mice.

Authors:  Paul W Denton; J Victor Garcia
Journal:  Trends Microbiol       Date:  2012-04-12       Impact factor: 17.079

Review 2.  Pharmacokinetics and pharmacodynamics in HIV prevention; current status and future directions: a summary of the DAIDS and BMGF sponsored think tank on pharmacokinetics (PK)/pharmacodynamics (PD) in HIV prevention.

Authors:  Joseph Romano; Angela Kashuba; Stephen Becker; James Cummins; Jim Turpin; Fulvia Veronese
Journal:  AIDS Res Hum Retroviruses       Date:  2013-05-22       Impact factor: 2.205

3.  Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells.

Authors:  Tracy King; Lane Bushman; Jennifer Kiser; Peter L Anderson; Michelle Ray; Thomas Delahunty; Courtney V Fletcher
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-07-07       Impact factor: 3.205

Review 4.  The use of nonhuman primate models of HIV infection for the evaluation of antiviral strategies.

Authors:  Koen K A Van Rompay
Journal:  AIDS Res Hum Retroviruses       Date:  2011-10-19       Impact factor: 2.205

5.  One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates.

Authors:  Paul W Denton; Florence Othieno; Francisco Martinez-Torres; Wei Zou; John F Krisko; Elisa Fleming; Sima Zein; Daniel A Powell; Angela Wahl; Youn Tae Kwak; Brett D Welch; Michael S Kay; Deborah A Payne; Philippe Gallay; Ettore Appella; Jacob D Estes; Min Lu; J Victor Garcia
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

Review 6.  Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development.

Authors:  Iftekhar Mahmood
Journal:  Adv Drug Deliv Rev       Date:  2007-08-16       Impact factor: 15.470

7.  Generation of HIV latency in humanized BLT mice.

Authors:  Paul W Denton; Rikke Olesen; Shailesh K Choudhary; Nancy M Archin; Angela Wahl; Michael D Swanson; Morgan Chateau; Tomonori Nochi; John F Krisko; Rae Ann Spagnuolo; David M Margolis; J Victor Garcia
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

8.  Human breast milk and antiretrovirals dramatically reduce oral HIV-1 transmission in BLT humanized mice.

Authors:  Angela Wahl; Michael D Swanson; Tomonori Nochi; Rikke Olesen; Paul W Denton; Morgan Chateau; J Victor Garcia
Journal:  PLoS Pathog       Date:  2012-06-14       Impact factor: 6.823

9.  Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice.

Authors:  Paul W Denton; John F Krisko; Daniel A Powell; Melissa Mathias; Youn Tae Kwak; Francisco Martinez-Torres; Wei Zou; Deborah A Payne; Jacob D Estes; J Victor Garcia
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

10.  Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice.

Authors:  Paul W Denton; Jacob D Estes; Zhifeng Sun; Florence A Othieno; Bangdong L Wei; Anja K Wege; Daniel A Powell; Deborah Payne; Ashley T Haase; J Victor Garcia
Journal:  PLoS Med       Date:  2008-01-15       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.